This Article Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by SUDA, T. Articles by SHIZUME, K. Search for Related Content PubMed PubMed Citation Articles by SUDA, T. Articles by SHIZUME, K.

Responses to Corticotropin-Releasing Hormone and Its Bound and Free Forms in Pregnant and Nonpregnant Women^*

Department of Medicine, Institute of Clinical Endocrinology Tokyo 162, Japan
Maternal Division, Maternal and Perinatal Center, Tokyo Women's Medical College Tokyo 162, Japan

Address requests for reprints to: Toshihiro Suda, M.D., Department of Medicine, Institute of Clinical Endocrinology, Tokyo Women's Medical College, 8–1 Kawada-cho, Shinjuku-ku, Tokyo 162, Japan.

Plasma CRH levels are considerably higher in women during the third trimester of pregnancy than in nonpregnant women. Most of plasma CRH in pregnant women is bound to CRH-binding protein (CRH-BP). To gain further insight into CRH physiology during pregnancy, we measured the responses of plasma ACTH and cortisol and the changes in bound and free forms of CRH in plasma after human CRH administration (2 µg/kg) in five pregnant (39–40 weeks of pregnancy) and five nonpregnant women. The mean basal plasma ACTH and cortisol levels in the pregnant women were higher than those in the nonpregnant women. However, the maximum increments in plasma ACTH and cortisol levels and the integrated ACTH and cortisol responses, after subtraction of the basal levels after CRH administration, were similar in the two groups. The plasma CRH half-time in the pregnant group was similar to that in the nonpregnant group. The mean basal plasma CRH level in the nonpregnant women was 1.5 ± 0.2 (±SE) pmol/L, and that in the pregnant women was 360 ± 35 pmol/L. On gel filtration chromatography, almost all of the CRH in the plasma was protein bound (320 ± 30 pmol/L) in the pregnant women; no CRH peaks were detected in nonpregnant women because of the low plasma CRH levels. After CRH administration, the level of the bound form of plasma CRH was highest at 5 min, and then declined to a plateau at 15 min and 30 min in the pregnant women. In the nonpregnant women, protein-bound CRH also was highest at 5 min, but it progressively declined thereafter. The disappearance rate of the bound CRH in plasma from the nonpregnant women was similar to that of the second compartment of the plasma decay curves of the free CRH from both groups. We conclude that the plasma ACTH and cortisol responses to exogenous CRH are similar in pregnant and nonpregnant women, the effect of CRH-BP on the disappearance of plasma CRH is minimal, and plasma CRH-BP in pregnant women has the capacity to bind additional CRH.

^* This work was supported in part by Grant-in-Aid 62570520 for General Scientific Research from the Japanese Ministry of Education, Science, and Culture, and a Research Grant for Intractable Disease from the Japanese Ministry of Health and Welfare.

Received December 20, 1988.

This article has been cited by other articles:

				J. R. Lindsay and L. K. Nieman The Hypothalamic-Pituitary-Adrenal Axis in Pregnancy: Challenges in Disease Detection and Treatment Endocr. Rev., October 1, 2005; 26(6): 775 - 799. [Abstract] [Full Text] [PDF]

				J. R. Lindsay, J. Jonklaas, E. H. Oldfield, and L. K. Nieman Cushing's Syndrome during Pregnancy: Personal Experience and Review of the Literature J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 3077 - 3083. [Abstract] [Full Text] [PDF]